Economic modeling in chronic obstructive pulmonary disease.
暂无分享,去创建一个
[1] M P Rutten-van Mölken,et al. The impact of aging and smoking on the future burden of chronic obstructive pulmonary disease: a model analysis in the Netherlands. , 2001, American journal of respiratory and critical care medicine.
[2] Philip Jacobs,et al. Cost-effectiveness of inhaled corticosteroids for chronic obstructive pulmonary disease according to disease severity. , 2004, The American journal of medicine.
[3] Cesar G Victora,et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study , 2005, The Lancet.
[4] C. Victora,et al. The Platino project: methodology of a multicenter prevalence survey of chronic obstructive pulmonary disease in major Latin American cities , 2004, BMC medical research methodology.
[5] Jan B Oostenbrink,et al. Probabilistic Markov model to assess the cost-effectiveness of bronchodilator therapy in COPD patients in different countries. , 2005, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[6] W. Bailey,et al. Effects of Smoking Intervention and the Use of an Inhaled Anticholinergic Bronchodilator on the Rate of Decline of FEV1 , 1994 .
[7] D. Postma,et al. Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease , 2005, Thorax.
[8] R. Pauwels,et al. Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial , 2003, The Lancet.
[9] D. Nowak,et al. Epidemiology and Health Economics of COPD Across Europe , 2005, Treatments in respiratory medicine.
[10] Sean D Sullivan,et al. A computer simulation model of the natural history and economic impact of chronic obstructive pulmonary disease. , 2004, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[11] E F M Wouters,et al. A dynamic population model of disease progression in COPD , 2005, European Respiratory Journal.
[12] J C Jager,et al. Current and future medical costs of asthma and chronic obstructive pulmonary disease in The Netherlands. , 1999, Respiratory Medicine.